Sign in
4

Changes in Ownership

COGNITION THERAPEUTICS INC Filed Acc 0001062993-23-010091

Chief Financial Officer acquired 109,824 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doyle John Brendan · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-01 Grant or award : show line 1 in the form +109,824 109,824 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-01 Grant or award : show line 2 in the form Stock Option (right to buy) +109,824 109,824 D
Loading xslF345X04/form4.xml…